Ron Cohen - Mar 16, 2023 Form 4 Insider Report for Acorda Therapeutics, Inc. (ACOR)

Role: President and CEO, Director
Signature: /s/ Ron Cohen
Stock symbol: ACOR
Transactions as of: Mar 16, 2023
Transactions value $: $12,594
Form type: 4
Date filed: 3/20/2023, 04:29 PM
Previous filing: Mar 21, 2022
Next filing: Apr 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ACOR	Common Stock	Purchase	$6.09K	+10.2K	+7.84%	$0.60	140K	Mar 16, 2023	Direct	F1
transaction	ACOR	Common Stock	Purchase	$6.5K	+10K	+7.16%	$0.65	150K	Mar 17, 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.590 to $0.600. The reporting person undertakes to provide to Acorda Therapeutics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.590 to $0.600. The reporting person undertakes to provide to Acorda Therapeutics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.